Terms: = Endocrine gland cancer AND COL1A1, P02452, 1277, ENSG00000108821, OI4 AND Treatment
20 results:
1. Anti-tumorigenic effects of naive and TLR4-primed adipose-derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells.
Kaçaroğlu D; Yaylacı S; Gurbuz N
Cancer Med; 2024 Jan; 13(2):e6964. PubMed ID: 38379331
[TBL] [Abstract] [Full Text] [Related]
2. Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer.
Liu Z; Hayashi H; Matsumura K; Ogata Y; Sato H; Shiraishi Y; Uemura N; Miyata T; Higashi T; Nakagawa S; Mima K; Imai K; Baba H
Br J Cancer; 2023 Mar; 128(5):844-856. PubMed ID: 36536047
[TBL] [Abstract] [Full Text] [Related]
3. Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation.
Javanshir HT; Malekraeisi MA; Ebrahimi SSS; Bereimipour A; Kashani SF; Bostaki AA; Mahmoodzadeh H; Nayernia K
J Med Life; 2022 Sep; 15(9):1143-1157. PubMed ID: 36415513
[TBL] [Abstract] [Full Text] [Related]
4. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
[TBL] [Abstract] [Full Text] [Related]
5. MALDI-MSI: A Powerful Approach to Understand Primary Pancreatic Ductal Adenocarcinoma and Metastases.
Gonçalves JPL; Bollwein C; Schlitter AM; Kriegsmann M; Jacob A; Weichert W; Schwamborn K
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956764
[TBL] [Abstract] [Full Text] [Related]
6. Effects of interobserver and interdisciplinary segmentation variabilities on CT-based radiomics for pancreatic cancer.
Wong J; Baine M; Wisnoskie S; Bennion N; Zheng D; Yu L; Dalal V; Hollingsworth MA; Lin C; Zheng D
Sci Rep; 2021 Aug; 11(1):16328. PubMed ID: 34381070
[TBL] [Abstract] [Full Text] [Related]
7. Identifying gene modules of thyroid cancer associated with pathological stage by weighted gene co-expression network analysis.
Tang X; Huang X; Wang D; Yan R; Lu F; Cheng C; Li Y; Xu J
Gene; 2019 Jul; 704():142-148. PubMed ID: 30965127
[TBL] [Abstract] [Full Text] [Related]
8. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
[TBL] [Abstract] [Full Text] [Related]
9. Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment.
Bachmayer S; Fastner G; Vaszi A; Iglseder W; Kopp P; Holzinger J; Dinnewitzer A; Rinnerthaler G; Gampenrieder SP; Emmanuel K; Greil R; Sedlmayer F; Zehentmayr F
Strahlenther Onkol; 2018 Jul; 194(7):627-637. PubMed ID: 29497791
[TBL] [Abstract] [Full Text] [Related]
10. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Lawrie TA; Winter-Roach BA; Heus P; Kitchener HC
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004706. PubMed ID: 26676202
[TBL] [Abstract] [Full Text] [Related]
11. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
[TBL] [Abstract] [Full Text] [Related]
12. Connecting prognostic ligand receptor signaling loops in advanced ovarian cancer.
Eng KH; Ruggeri C
PLoS One; 2014; 9(9):e107193. PubMed ID: 25244152
[TBL] [Abstract] [Full Text] [Related]
13. Impact of combination chemotherapy with itraconazole on survival for patients with recurrent or persistent ovarian clear cell carcinoma.
Tsubamoto H; Sonoda T; Yamasaki M; Inoue K
Anticancer Res; 2014 Apr; 34(4):2007-14. PubMed ID: 24692739
[TBL] [Abstract] [Full Text] [Related]
14. Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells.
Yu PN; Yan MD; Lai HC; Huang RL; Chou YC; Lin WC; Yeh LT; Lin YW
Int J Cancer; 2014 Feb; 134(3):542-51. PubMed ID: 23904094
[TBL] [Abstract] [Full Text] [Related]
15. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Lawrie TA
Cochrane Database Syst Rev; 2012 Mar; 3(3):CD004706. PubMed ID: 22419298
[TBL] [Abstract] [Full Text] [Related]
16. Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.
Zeller C; Dai W; Steele NL; Siddiq A; Walley AJ; Wilhelm-Benartzi CS; Rizzo S; van der Zee A; Plumb JA; Brown R
Oncogene; 2012 Oct; 31(42):4567-76. PubMed ID: 22249249
[TBL] [Abstract] [Full Text] [Related]
17. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jul; (3):CD004706. PubMed ID: 19588360
[TBL] [Abstract] [Full Text] [Related]
18. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
[TBL] [Abstract] [Full Text] [Related]
19. Stage I testicular seminoma: para-aortic and iliac irradiation with reduced dose after orchiectomy.
Gürkaynak M; Akyol F; Zorlu F; Akyurek S; Yildiz F; Atahan IL
Urol Int; 2003; 71(4):385-8. PubMed ID: 14646438
[TBL] [Abstract] [Full Text] [Related]
20. Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies.
Guilhaume B; Bertagna X; Thomsen M; Bricaire C; Vila-Porcile E; Olivier L; Racadot J; Derome P; Laudat MH; Girard F
J Clin Endocrinol Metab; 1988 May; 66(5):1056-64. PubMed ID: 3360898
[TBL] [Abstract] [Full Text] [Related]
